Cyproterone acetate a potential male contraceptive further studies on the interactions with endocrine parameters
Moltz, L.; Rommler, A.; Schwartz, U.; Post, K.; Hammerstein, J.
Journal of Steroid Biochemistry 9(9): 865
1978
ISSN/ISBN: 0022-4731 Document Number: 438665
Document emailed within 1 workday
Related Documents
Hussain, M.; Kanamadi, R.D.; Saidapur, S.K. 1981: Effect of cyproterone acetate and cyproterone acetate + ascorbic acid on pars distalis of the toad Bufo melanostictus Indian Journal of Experimental Biology 19(11): 1061-1062Neumann, F. 1977: Pharmacology and potential use of cyproterone acetate Hormone and Metabolic Research 9(1): 1-13
Wu, J.; Zhu, Y.; Jiang, Y.; Cao, Y. 2008: Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 24(7): 392-398
Vartiainen, M.; de Gezelle, H.; Broekmeulen, C.J. 2001: Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 6(1): 46-53
Gode, F.; Karagoz, C.; Posaci, C.; Saatli, B.; Uysal, D.; Secil, M.; Akdeniz, B. 2011: Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate Archives of Gynecology and Obstetrics 284(4): 923-929
Scheuer, A.; Dahnke, H.G.; Mosebach, K.O. 1971: Changes in nuleic acid concentrations in some organs of growing male rats and their influencing by cyproterone acetate and testosterone Acta Endocrinologica. Supplementum 152: 34
Koch, U.J.; Lorenz, F.; Danehl, K.; Ericsson, R.; Hasan, S.H.; Keyserlingk, D.V.; Lübke, K.; Mehring, M.; Römmler, A.; Schwartz, U.; Hammerstein, J. 1976: Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? a trend analysis in 15 volunteers Contraception 14(2): 117-135
Kapur, R.; Stramrood, C.A.I.; Schutgens, R.E.G.; van Asbeck, B.Sweder. 2009: Cyproterone acetate- and ethinyloestradiol-containing oral contraceptive as a risk factor for upper extremity deep venous thrombosis-a case report European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 14(2): 160-163
Markantes, G.; Saltamavros, A.D.; Vervita, V.; Armeni, A.K.; Karela, A.; Adonakis, G.; Decavalas, G.; Georgopoulos, N.A. 2011: Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(12): 971-977
Kahraman, K.; Sükür, Y.E.; Atabekoğlu, C.S.; Ateş, C.; Taşkın, S.; Cetinkaya, S.E.; Tolunay, H.E.; Ozmen, B.; Sönmezer, M.; Berker, B.ül. 2014: Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial Archives of Gynecology and Obstetrics 290(2): 321-328
Bhattacharya, S.M.; Jha, A. 2012: Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome Fertility and Sterility 98(4): 1053-1059
Grabski, J. 1975: Biometric evaluation of relative DNA and histone concentration in rabbit spermatozoa following administration of cyproterone acetate. Microcytophotometric studies Ginekologia Polska 46(9): 951-958
Cooper, A.J.; Sandhu, S.; Losztyn, S.; Cernovsky, Z. 1992: A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 37(10): 687-693
O'Rand, M.G.; Hamil, K.G.; Adevai, T.; Zelinski, M. 2018: Inhibition of sperm motility in male macaques with EP055, a potential non-hormonal male contraceptive Plos one 13(4): E0195953
Cursino, K.; Sider, M.; Pavin, E.J.ão.; dos Santos, P.d.N.é S.; Bahamondes, L.; Zantut-Wittmann, D.E.; Fernandes, A. 2016: Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 21(1): 22-29
Ågren, U.M.; Anttila, M.; Mäenpää-Liukko, K.; Rantala, M.-L.; Rautiainen, H.; Sommer, W.F.; Mommers, E. 2011: Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 16(6): 458-467
Bain, J.; Rachlis, V.; Robert, E.; Khait, Z. 1980: The combined use of oral medroxyprogesterone acetate and methyltestosterone in a male contraceptive trial programme Contraception 21(4): 365-379
Doody, K.; Bain, J. 1985: The effect of oral medroxyprogesterone acetate and methyltestosterone on sexual functioning in a male contraceptive trial Contraception 31(1): 65-70
Minozzi, M.; Costantino, D.; Guaraldi, C.; Unfer, V. 2011: The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(11): 920-924
Shetty, G.; Krishnamurthy, H.; Krishnamurthy, H.N.; Ramachandra, S.G.; Moudgal, N.R. 1997: Use of norethisterone and estradiol in mini doses as a contraceptive in the male. Efficacy studies in the adult male bonnet monkey (Macaca radiata) Contraception 56(4): 257-265